Pliant Therapeutics (PLRX) Other Non-Current Assets (2019 - 2026)

Pliant Therapeutics (PLRX) has 8 years of Other Non-Current Assets data on file, last reported at $1.5 million in Q1 2026.

• Other Non-Current Assets for Q1 2026 came in at $1.5 million, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.5 million (changed 0.0% YoY), and the FY2025 annual result was $392000.0, down 73.55% from the prior year.
• Other Non-Current Assets climbed to $1.5 million in Q1 2026 per PLRX's latest filing, from $392000.0 in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $1.5 million in Q4 2023 and troughed at $392000.0 in Q3 2025.
• A 5-year average of $1.1 million and a median of $1.5 million in 2023 frame the typical range for Other Non-Current Assets.
• The sharpest annual moves came in 2022 and 2025: Other Non-Current Assets jumped 85.14% in 2022, then tumbled 73.55% in 2025.
• A 5-year view of Other Non-Current Assets shows it stood at $397000.0 in 2022, then soared by 273.3% to $1.5 million in 2023, then changed by 0.0% to $1.5 million in 2024, then plunged by 73.55% to $392000.0 in 2025, then surged by 278.06% to $1.5 million in 2026.
• Business Quant data shows PLRX's Other Non-Current Assets at $1.5 million in Q1 2026, $392000.0 in Q4 2025, and $392000.0 in Q3 2025.